Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-057491

SVP & Chief Accounting Officer sold 2,713 shares at $17.97 ($48,753)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. SVP & Chief Accounting Officer 2019-11-18 Sale −2,713 $17.97 $48,753 160,441 D: show line 1 in the form
Open-market sales · 2,713 sh · avg $17.97 · $48,753
Loading xslF345X03/doc4.xml…